Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids.

Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y, Putnam WS, Parsey MV, Bohen SP, Matthews JG.

J Allergy Clin Immunol. 2013 Sep;132(3):567-574.e12. doi: 10.1016/j.jaci.2013.03.051. Epub 2013 May 29.

PMID:
23726041
2.

Lebrikizumab treatment in adults with asthma.

Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG.

N Engl J Med. 2011 Sep 22;365(12):1088-98. doi: 10.1056/NEJMoa1106469. Epub 2011 Aug 3.

3.

Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.

Donohue JF, Parsey MV, Andrews C, D'Urzo T, Sharma S, Schaefer K, Claus R, Baumgartner RA; Levalbuterol COPD Study Group.

COPD. 2006 Aug;3(3):125-32.

PMID:
17240614
4.

Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.

Berger WE, Milgrom H, Skoner DP, Tripp K, Parsey MV, Baumgartner RA; Xopenex Pediatric Asthma Group.

Curr Med Res Opin. 2006 Jun;22(6):1217-26.

PMID:
16846555
5.

A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.

Nowak R, Emerman C, Hanrahan JP, Parsey MV, Hanania NA, Claus R, Schaefer K, Baumgartner RA; XOPENEX Acute Severe Asthma Study Group.

Am J Emerg Med. 2006 May;24(3):259-67.

PMID:
16635694
6.

Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1beta.

Parsey MV, Kaneko D, Shenkar R, Abraham E.

Chest. 1999 Jul;116(1 Suppl):67S-68S. No abstract available.

PMID:
10424597
7.

Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of IL-1beta.

Parsey MV, Kaneko D, Shenkar R, Abraham E.

Clin Immunol. 1999 May;91(2):219-25.

PMID:
10227814
8.
9.

Supplemental Content

Loading ...
Support Center